Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Renin Angiotensin System Blockers and Risk of Mortality in Hypertensive Patients Hospitalized for COVID-19: An Italian Registry
Fabio Angeli, Paolo Verdecchia, Antonella Balestrino, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 1, pp. 15-15
Open Access | Times Cited: 18

Showing 18 citing articles:

Endothelial Dysfunction in COVID-19: A Unifying Mechanism and a Potential Therapeutic Target
Pasquale Ambrosino, Ilenia Calcaterra, Marco Mosella, et al.
Biomedicines (2022) Vol. 10, Iss. 4, pp. 812-812
Open Access | Times Cited: 52
COVID-19, vaccines and deficiency of ACE2 and other angiotensinases. Closing the loop on the "Spike effect"
Fabio Angeli, Gianpaolo Reboldi, Monica Trapasso, et al.
European Journal of Internal Medicine (2022) Vol. 103, pp. 23-28
Open Access | Times Cited: 47
Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019
Jordan Swiderski, Laura Kate Gadanec, Vasso Apostolopoulos, et al.
Biomolecules (2023) Vol. 13, Iss. 5, pp. 787-787
Open Access | Times Cited: 21
Blood Pressure Increase following COVID-19 Vaccination: A Systematic Overview and Meta-Analysis
Fabio Angeli, Gianpaolo Reboldi, Monica Trapasso, et al.
Journal of Cardiovascular Development and Disease (2022) Vol. 9, Iss. 5, pp. 150-150
Open Access | Times Cited: 36
Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic Options
Maria Chiara Pelle, Isabella Zaffina, Stefania De Luca, et al.
Life (2022) Vol. 12, Iss. 10, pp. 1605-1605
Open Access | Times Cited: 34
Charlson comorbidity index, neutrophil-to-lymphocyte ratio and undertreatment with renin-angiotensin-aldosterone system inhibitors predict in-hospital mortality of hospitalized COVID-19 patients during the omicron dominant period
Andrea Sonaglioni, Michele Lombardo, Adriana Albini, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 19
The spike effect of acute respiratory syndrome coronavirus 2 and coronavirus disease 2019 vaccines on blood pressure
Fabio Angeli, Martina Zappa, Gianpaolo Reboldi, et al.
European Journal of Internal Medicine (2022) Vol. 109, pp. 12-21
Open Access | Times Cited: 17
Rethinking the Role of the Renin-Angiotensin System in the Pandemic Era of SARS-CoV-2
Fabio Angeli, Martina Zappa, Paolo Verdecchia
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 1, pp. 14-14
Open Access | Times Cited: 6
Impact of hypertension on long-term humoral and cellular response to SARS-CoV-2 infection
Chang Chu, Anne Schönbrunn, Kristin Klemm, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Relation Between Renin–Angiotensin–Aldosterone System Inhibitors and COVID-19 Severity
Mousa J Alhaddad, Mohammed S Almulaify, Abdullah A Alshabib, et al.
Cureus (2022)
Open Access | Times Cited: 6
Association of outpatient use of renin–angiotensin–aldosterone system blockers on outcomes of acute respiratory illness during the COVID-19 pandemic: a cohort study
Molly M. Jeffery, Lucas Oliveira J. e Silva, Fernanda Bellolio, et al.
BMJ Open (2022) Vol. 12, Iss. 7, pp. e060305-e060305
Open Access | Times Cited: 6
Comparing clinical outcomes of ARB and ACEi in patients hospitalized for acute COVID-19
Seiji Hamada, Tomoharu Suzuki, Yasuharu Tokuda, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
The effects of antihypertensive medications on severity and outcomes of COVID19
Mehmet Ağırbaşlı
Journal of Human Hypertension (2022) Vol. 36, Iss. 10, pp. 875-879
Open Access | Times Cited: 4
Biomarkers, Pandemics and Host Response Treatment
David S. Fedson
Journal of Nursing & Healthcare (2024) Vol. 9, Iss. 2, pp. 01-15
Open Access
mRNA Metabolism and Hypertension
Martina Zappa, Paolo Verdecchia, Antonio Spanevello, et al.
Biomedicines (2023) Vol. 11, Iss. 1, pp. 118-118
Open Access | Times Cited: 1
The dynamics of hypertension and renal function in CKD and non-CKD patients affected with COVID-19 – final results of BIRCOV trial
Д.Д. Іванов, Antolii Gozhenko, Mariia Ivanova, et al.
European Journal of Clinical and Experimental Medicine (2023) Vol. 21, Iss. 2, pp. 230-238
Open Access | Times Cited: 1
Complications of SARS-CoV-2 Infection During Cardiac Rehabilitation: A Case Series
Martina Zappa, Paolo Verdecchia, Andrea Andolina, et al.
Cardiology and Therapy (2023) Vol. 12, Iss. 3, pp. 533-538
Open Access | Times Cited: 1
New Perspectives and Strategies for the Management of Hypertension
Fabio Angeli
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 8, pp. 346-346
Open Access
Page 1

Scroll to top